Maccura Biotechnology (300463.SZ) has received a medical device registration certificate.
Mike Biology (300463.SZ) announced that the company recently received the "Medical Device Manufacturing License" issued by the Sichuan Provincial Drug Administration.
Maccura Biotechnology (300463.SZ) announced that the company recently received the "Medical Device Registration Certificate (In Vitro Diagnostic Reagent)" issued by the Sichuan Provincial Drug Administration. The product is named: Thyroid Stimulating Hormone Receptor Antibody Test Kit (Direct Chemiluminescence Method). The Thyroid Stimulating Hormone Receptor Antibody Test Kit (Direct Chemiluminescence Method) is mainly used for the auxiliary diagnosis of toxic diffuse goiter and is a new product on the company's direct chemiluminescence technology platform.
Related Articles

Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


